22 November 2017
News and Views
Links and Services
May's issue of Inflammatory Bowel Diseases investigates prognostic factors for clinical benefit of adalimumab in steroid-dependent Crohn's disease patients.
Corticosteroids are effective in the treatment of Crohn's disease but some patients relapse durin
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors